Showing results (41-50 of 72) with videos related to
Sort By:
Pageof 8
Hepatology Communications|May 19, 2023
Peroxisome proliferator-activated receptor γ activation ameliorates liver fibrosis-differential action of transcription factor EB and autophagy on hepatocytes and stellate cellsYunjin J Yum, Jin Yoo, Kyuhoon Bang, et al.Diabetes Research and Clinical Practice|September 6, 2022
Association between carotid atherosclerosis and presence of intracranial atherosclerosis using three-dimensional high-resolution vessel wall magnetic resonance imaging in asymptomatic patients with type 2 diabetesJi Eun Jun, You-Cheol Hwang, Kyu Jeong Ahn, et al.Pharmaceuticals (Basel, Switzerland)|August 29, 2024
A Compound Containing Aldehyde Dehydrogenase Relieves the Effects of Alcohol Consumption and Hangover Symptoms in Healthy Men: An Open-Labeled Comparative StudyIn-Kyung Jeong, Anna Han, Ji Eun Jun, et al.Journal of Bone Metabolism|February 14, 2014
Validation of a new food frequency questionnaire for assessment of calcium and vitamin d intake in korean womenYongsoon Park, Sang-Hee Kim, Yong-Taek Lim, et al.Life Sciences|August 1, 2013
Bisphenol A reduces differentiation and stimulates apoptosis of osteoclasts and osteoblastsJin Kyung Hwang, Kwan Hee Min, Kyoung Hee Choi, et al.Bone|September 26, 2006
Eosinophil chemotactic factor-L (ECF-L) enhances osteoclast formation by increasing in osteoclast precursors expression of LFA-1 and ICAM-1Veronica Garcia-Palacios, Ho Yeon Chung, Sun Jin Choi, et al.Journal of Bone Metabolism|February 14, 2014
Changes in Serum Osteocalcin are Not Associated with Changes in Glucose or Insulin for Osteoporotic Patients Treated with BisphosphonateSeong-Hun Hong, Ja-Won Koo, Jin Kyung Hwang, et al.Frontiers in Endocrinology|July 2, 2026
Dulaglutide versus empagliflozin as add-on therapy to metformin and sulfonylurea in type 2 diabetes: a randomized pilot study with exploratory metabolomic and microbiome analysesJi Eun Jun, Da-Hee Oh, In-Kyung Jeong, et al.Experimental Hematology|February 26, 2005
MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cellsYasuo Oba, Jun Won Lee, Lori A Ehrlich, et al.Endocrinology and Metabolism (Seoul, Korea)|December 11, 2014
Acromegaly with Normal Insulin-Like Growth Factor-1 Levels and Congestive Heart Failure as the First Clinical ManifestationHyae Min Lee, Sun Hee Lee, In Ho Yang, et al.Pageof 8